The PIK3CA (H1047R) mutation has been correlated with poor clinical prognosis not only in gastric carcinoma, glioblastoma, and colorectal carcinoma [18] but also in breast cancer [19,20]. This evidence concerns the gene PIK3CA and glioblastoma.